Isofol Medical
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
ISOFOL | ST
Overview
Corporate Details
- ISIN(s):
- SE0009581051
- LEI:
- 549300MCXYAHG7VBHX75
- Country:
- Sweden
- Address:
- C/O Biotech Center, Arvid Wallgrens, 413 46 Göteborg
- Website:
- https://isofolmedical.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Isofol Medical AB is a research-based biotechnology company focused on improving the prognosis for patients with severe forms of cancer. The company develops its primary drug candidate, arfolitixorin, with the aim of increasing the efficacy of first-line standard chemotherapy treatments for various solid tumors. A key area of development is colorectal cancer, where the company is conducting a Phase Ib/II clinical study to optimize the drug candidate's dosing regimen and therapeutic effect.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-23 10:45 |
Major Shareholding Notification
|
Swedish | 10.5 KB | ||
| 2025-08-26 08:00 |
Interim Report
|
Swedish | 7.2 MB | ||
| 2025-08-26 08:00 |
Interim Report
|
English | 2.6 MB | ||
| 2025-07-31 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Nytt antal aktier och röster i Isofol
|
Swedish | 60.6 KB | ||
| 2025-07-31 08:00 |
Declaration of Voting Results & Voting Rights Announcements
New number of shares and votes in Isofol
|
English | 61.3 KB | ||
| 2025-07-04 18:00 |
Regulatory News Service
Isofol's rights issue fully subscribed – exercises overallotment for Japanese p…
|
English | 128.5 KB | ||
| 2025-07-04 18:00 |
Share Issue/Capital Change
Isofols företrädesemission övertecknad – utnyttjar övertilldelning till japansk…
|
Swedish | 127.3 KB | ||
| 2025-06-17 08:40 |
Prospectus
Isofol offentliggör prospekt i samband med bolagets företrädesemission
|
Swedish | 98.7 KB | ||
| 2025-06-17 08:40 |
Prospectus
Isofol publishes prospectus in connection with the company’s rights issue
|
English | 119.6 KB | ||
| 2025-06-11 14:00 |
Post-Annual General Meeting Information
Bulletin from extraordinary general meeting in Isofol Medical AB (publ) held on…
|
English | 94.5 KB | ||
| 2025-06-11 14:00 |
Post-Annual General Meeting Information
Kommuniké från extra bolagsstämma i Isofol Medical AB (publ) den 11 juni 2025
|
Swedish | 74.5 KB | ||
| 2025-06-05 08:30 |
Share Issue/Capital Change
Isofol offentliggör slutliga villkor i företrädesemission samt för en potentiel…
|
Swedish | 142.5 KB | ||
| 2025-06-05 08:30 |
Share Issue/Capital Change
Isofol announces final terms of the rights issue and the potential overallotmen…
|
English | 167.4 KB | ||
| 2025-05-21 16:40 |
Post-Annual General Meeting Information
Bulletin from annual general meeting in Isofol Medical AB (publ) held on May 21…
|
English | 95.5 KB | ||
| 2025-05-21 16:40 |
Post-Annual General Meeting Information
Kommuniké från årsstämma i Isofol Medical AB (publ) den 21 maj 2025
|
Swedish | 90.1 KB |
Automate Your Workflow. Get a real-time feed of all Isofol Medical filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Isofol Medical via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2020-06-05 | Gustaf Albèrt | Other | Other | 1,542 | 5,397.00 SEK |
| 2020-06-02 | HealthCom GmbH | Other | Buy | 133,336 | 466,676.00 SEK |
| 2020-06-01 | Gustaf Albèrt | Other | Other | 10,664 | 37,324.00 SEK |
| 2020-06-01 | Sven Eriksson | Other | Other | 9,332 | 32,662.00 SEK |
| 2020-06-01 | Sven Eriksson | Other | Other | 9,223 | 32,280.50 SEK |
